Phase I/II Study of Linperlisib Plus Chidamide for R/R Cutaneous T-cell Lymphoma: a Prospective, Single-center Study
Clinical trial NCT06037239 · UNKNOWN
Trial details
- NCT number
- NCT06037239
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.